Isoxazole 9 (ISX-9)

For research use only.

Catalog No.S7914

Isoxazole 9 (ISX-9) Chemical Structure

CAS No. 832115-62-5

Isoxazole 9 (Isx-9) is a synthetic promotor of adult neurogenesis by triggering neuronal differentiation of adult neural stem/precursor cells (NSPCs). Isoxazole 9 (Isx-9) activates multiple pathways including TGF-β induced epithelial–mesenchymal transition (EMT) signaling, canonical and non-canonical Wnt signaling at different stages of cardiac differentiation.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 117 In stock
USD 117 In stock
USD 347 In stock
USD 797 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective Wnt/beta-catenin Inhibitors

Biological Activity

Description Isoxazole 9 (Isx-9) is a synthetic promotor of adult neurogenesis by triggering neuronal differentiation of adult neural stem/precursor cells (NSPCs). Isoxazole 9 (Isx-9) activates multiple pathways including TGF-β induced epithelial–mesenchymal transition (EMT) signaling, canonical and non-canonical Wnt signaling at different stages of cardiac differentiation.
In vitro

In NSPCs, isoxazole 9 increases cell number, and promotes cell differentiation. In OPCs, isoxazole 9 induces cell damage. In outgrowth EPCs, isoxazole 9 decreases tube formation without effect on early EPCs. [1]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HCN NYj1To0{TnWwY4Tpc44h[XO|YYm= M2T6O2lv\HWldHnvckBw\iCQTVTBJJJm[2WydH;yMY1m\GmjdHXkJGNiOitiaX7mcJV5KGmwIILheEBJS05iY3XscJMhcW5icILld4Vv[2Vib3[gUm1FSSC{ZXPldJRweiCjboTh[49vcXO2IF3LPFAy MnPCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh3NUK4N|IoRjF6NUWyPFMzRC:jPh?=
HCN MmfDSpVv[3Srb36gZZN{[Xl? NUPYT2NHPSC3TR?= NW\uSXlkUW6mdXP0bY9vKG:oIFyteJlx\SClYXzjbZVuKGOqYX7u[YwwVk2GQTDy[YNmeHSxcj3t[YRq[XSnZDDDZVIsKGmwZnz1fEBqdiC{YYSgTGNPKGOnbHzzJIF1KDVidV2gZpkhTnW{YT2yJIlu[WerbnegZY5idHm|aYOgbY4heHKnc3XuZ4Uhd2ZibYXseIlxdGVib3[gbY5pcWKrdH;ydy=> M4X5OFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NUWyPFMzLz5zOEW1Nlg{OjxxYU6=
HCN MkLaSpVv[3Srb36gZZN{[Xl? M17aNFUxKHWP NIriZ3U{KGi{cx?= NWDMT2o{UW6mdXP0bY9vKG:oIF7NSGEhemWlZYD0c5IudWWmaXH0[YQhdmW3cn;EJIdmdmViZYjwdoV{e2mxbjDpckBz[XRiSFPOJINmdGy|IHH0JFUxKHWPIHHmeIVzKDNiaILzJIJ6KFKWLWDDVkBidmGueYPpd{BqdiCycnXz[Y5k\SCxZjDOUWRCKHKnY3XweI9zKGGwdHHnc45qe3RiTVu4NFE> MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDV3MkizNkc,OTh3NUK4N|I9N2F-
HCN M1z1bGZ2dmO2aX;uJIF{e2G7 Mle0NlUhfU1? MlTNOEBl[Xm| NYrrPY9iUW6qaXLpeIlwdiCxZjDncIlw\2WwZYPpd{BlcW[oZYLlcpRq[XSrb36gbY4hemG2IFjDUkBk\WyuczDheEAzPSC3TTDh[pRmeiB2IHThfZM> M2HBO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NUWyPFMzLz5zOEW1Nlg{OjxxYU6=
HCN MmnDSpVv[3Srb36gZZN{[Xl? MYq1JJVO Ml:1TY5lfWO2aX;uJI9nKExvdInw[UBk[WylaYXtJINp[W6wZXyvUm1FSSC{ZXPldJRwei2vZXTpZZRm\CCFYUKrJIlv\my3eDDpckBz[XRiSFPOJINmdGy|IHH0JFUhfU1iYomgSpVz[S1{IHntZYdqdmdiYX7hcJl{cXN? MlTIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh3NUK4N|IoRjF6NUWyPFMzRC:jPh?=
HCN M1flNmZ2dmO2aX;uJIF{e2G7 NWi3e2dmPSC3TR?= Mn22TY5lfWO2aX;uJI9nKE6PRFGgdoVk\XC2b4KtcYVlcWG2ZXSgR4EzMyCrbn\seZghcW5icnH0JGhEViClZXzsd{BifCB3IIXNJIJ6KE[3cnGtNkBqdWGpaX7nJIFv[Wy7c3nzJIlvKHC{ZYPlcoNmKG:oIF7NSGEhemWlZYD0c5Ih[W62YXfvcol{fCCPS{iwNS=> MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDV3MkizNkc,OTh3NUK4N|I9N2F-
HCN M3;L[WZ2dmO2aX;uJIF{e2G7 NH\tU5o2OCC3TR?= NWH5NIFkOyCqcoO= NV3hV2RoUW6mdXP0bY9vKG:oIFyteJlx\SClYXzjbZVuKGOqYX7u[YwwVk2GQTDy[YNmeHSxcj3t[YRq[XSnZDDu[ZVzd0RiZ3Xu[UBmgHC{ZYPzbY9vKGmwIILheEBJS05iY3XscJMh[XRiNUCgeW0h[W[2ZYKgN{BpenNiYomgVnQuWEOUIHHuZYx6e2m|IHnuJJBz\XOnbnPlJI9nKG23bITpdIxmKGmwaHnibZRwenN? M1\KN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NUWyPFMzLz5zOEW1Nlg{OjxxYU6=
HCN M1TibGZ2dmO2aX;uJIF{e2G7 MlPsTY5lfWO2aX;uJI9nKExvdInw[UBk[WylaYXtJINp[W6wZXyvUm1FSSC{ZXPldJRwei2vZXTpZZRm\CCFYUKrJIlv\my3eDDpckBz[XRiSFPOJINmdGy| NW\GVWlvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVI5OzJpPkG4OVUzQDN{PD;hQi=>
HCN NHn5[HJHfW6ldHnvckBie3OjeR?= MYHJcoR2[3Srb36gc4YhVC22eYDlJINidGOrdX2gZ4hidm6nbD;OUWRCKHKnY3XweI9zNW2nZHnheIVlKEOjMjugbY5ndHW6IHnuJJJifCCKQ16gZ4VtdHNiaX6gdJJme2WwY3WgcZVtfGmybHWgbY5pcWKrdH;ydy=> NX;IOnY4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVI5OzJpPkG4OVUzQDN{PD;hQi=>
HCN NFuwfYpHfW6ldHnvckBie3OjeR?= NHvtfFg2OCC3TR?= M2\GSVI1KGi{cx?= MVHJcoR2[3Srb36gc4YhVk2GQTDy[YNmeHSxcj3t[YRq[XSnZDDu[ZVzd0RiZ3Xu[UBmgHC{ZYPzbY9vKGmwIILheEBJS05iY3XscJMh[XRiNUCgeW0h[W[2ZYKgNlQhcHK|IHL5JHJVNVCFUjDhcoFtgXOrczDpckBxemW|ZX7j[UBw\iCQTVTBJJJm[2WydH;yJIFvfGGpb37pd5QhVUt6MEG= NHTJZ4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEW1Nlg{Oid-MUi1OVI5OzJ:L3G+
HCN NYDvfYE{TnWwY4Tpc44h[XO|YYm= MXO1NEB2VQ>? MlXxNlQhcHK| M1TkWmlv\HWldHnvckBw\iCQTVTBJJJm[2WydH;yMY1m\GmjdHXkJI5mfXKxRDDn[Y5mKGW6cILld5Nqd25iaX6gdoF1KEiFTjDj[YxteyCjdDC1NEB2VSCjZoTldkAzPCCqcoOgZpkhWlRvUFPSJIFv[Wy7c3nzJIlvKHC{ZYPlcoNmKG:oIF7NSGEhemWlZYD0c5Ih[W62YXfvcol{fCCwaX\l[IlxcW6n NWDqVGlIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVI5OzJpPkG4OVUzQDN{PD;hQi=>
HCN M2G4SGZ2dmO2aX;uJIF{e2G7 MmCzOVAhfU1? MWeyOEBpenN? NFvWfo5KdmS3Y4Tpc44hd2ZiTD30fZBmKGOjbHPpeY0h[2ijbn7lcE9PVUSDIILlZ4VxfG:{LX3l[IlifGWmIH7leZJwTCCpZX7lJIV5eHKnc4Ppc44hcW5icnH0JGhEViClZXzsd{BifCB3MDD1UUBi\nSncjCyOEBpenNiYomgVnQuWEOUIHHuZYx6e2m|IHnuJJBz\XOnbnPlJI9nKG23bITpdIxmKGmwaHnibZRwenN? MkeyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh3NUK4N|IoRjF6NUWyPFMzRC:jPh?=
HCN MYfGeY5kfGmxbjDhd5NigQ>? MmHPPEB1dyB4NDD1US=> MWS5JIhzew>? M3e2VGlv\HWldHnvckBw\iCwZYXyc4dmdmW|aYOgbY4hfW6maX\m[ZJmdnSrYYTl[EBz[XRiSFPOJINmdGy|IHHzd4V{e2WmIHHzJG1CWDKDQjDwdo91\WmwIHzleoVtKGG2IEigeI8hPjRidV2gZYZ1\XJiOTDodpMh[nlicILveIVqdiCkbH;0eIlv\yCjbnHsfZNqew>? MkjMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh3NUK4N|IoRjF6NUWyPFMzRC:jPh?=
HCN NWrLNpA1TnWwY4Tpc44h[XO|YYm= NGG1WXNKdmS3Y4Tpc44hd2ZiSFTBR|UhfHKjboPsc4NifGmxbjDpckBkgXSxcHzhd40hd2ZicnH0JGhEViClZXzsd{Bie3Onc4Pl[EBieyCyaH;zdIhwenmuYYTl[EBJTEGFNTDhZ4N2dXWuYYTpc44> MnPmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh3NUK4N|IoRjF6NUWyPFMzRC:jPh?=
HCN Mn;YSpVv[3Srb36gZZN{[Xl? MoPNTY5lfWO2aX;uJI9nKEODTVutcYVlcWG2ZXSgUXJGgDNiYXP0bZZqfHliaX6gdoF1KEiFTjDj[YxteyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZkhcW5icILld4Vv[2Vib3[gNk42KHWPIIDveIF{e2m3bTDjbIFvdmWuIHnubIljcXSxcjDLUlkz M4fFUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NUWyPFMzLz5zOEW1Nlg{OjxxYU6=
HCN MlHHSpVv[3Srb36gZZN{[Xl? NHf4UXo5KHSxIE[0JJVO NVz6R5lQQSCqcoO= M{\lOWlv\HWldHnvckBw\iCwZYXyc4dmdmW|aYOgbY4hfW6maX\m[ZJmdnSrYYTl[EBz[XRiSFPOJINmdGy|IHHzd4V{e2WmIHHzJGdtWjJxMzDwdo91\WmwIHzleoVtKGG2IEigeI8hPjRidV2gZYZ1\XJiOTDodpMh[nlicILveIVqdiCkbH;0eIlv\yCjbnHsfZNqew>? NYXseVVTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVI5OzJpPkG4OVUzQDN{PD;hQi=>
HCN M4m4emZ2dmO2aX;uJIF{e2G7 M3:4XVYhcHK| M2\YPGlv\HWldHnvckBw\iCKRFHDOUBxcG:|cHjvdplt[XSrb36gbY4hemG2IFjDUkBk\WyuczDh[pRmeiB4IHjydy=> MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDV3MkizNkc,OTh3NUK4N|I9N2F-
HCN MYjGeY5kfGmxbjDhd5NigQ>? NYD4dm06OjRiaILz NEH4VFBKdmS3Y4Tpc44hd2ZiSFTBR|UheGixc4Doc5J6dGG2aX;uJIlvKHKjdDDIR24h[2WubIOgZYZ1\XJiMkSgbJJ{ NYrSeZRLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVI5OzJpPkG4OVUzQDN{PD;hQi=>
HCN MonlSpVv[3Srb36gZZN{[Xl? MXvJcoR2[3Srb36gc4YhUESDQ{WgeJJidnOub3PheIlwdiCrbjDueYNt\XW|IH;mJJJifCCKQ16gZ4VtdHNiYYPz[ZN{\WRiYYOgdIhwe3Cqb4L5cIF1\WRiSFTBR|Uh[WOldX31cIF1cW:w NVP5fItuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVI5OzJpPkG4OVUzQDN{PD;hQi=>
HCN MVHGeY5kfGmxbjDhd5NigQ>? MXi1JJVO MYPJcoR2[3Srb36gc4YhUESDQ{WgeJJidnOub3PheIlwdiCrbjDueYNt\XW|IH;mJJJifCCKQ16gZ4VtdHNiYYPz[ZN{\WRiYYOgS2ZRNUiGQVO1JHMzPTiDIGO0PVhCKG23dHHueEBnfXOrb36gdJJwfGWrbjDhZ4N2dXWuYYTpc44h[XRiNTD1UUBjgSCobIXvdoV{[2WwY3WgZZN{[Xl? NYrzeGF7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVI5OzJpPkG4OVUzQDN{PD;hQi=>
HCN M{HCXmZ2dmO2aX;uJIF{e2G7 MmjTOVAhfU1? MVSzJIhzew>? NYfQdJd[UW6mdXP0bY9vKG:oIF7NSGEhemWlZYD0c5IudWWmaXH0[YQhdmW3cn;EJIdmdmViZYjwdoV{e2mxbjDpckBz[XRiSFPOJINmdGy|IHH0JFUxKHWPIHHmeIVzKDNiaILzJIJ6KFKWLWDDVkBidmGueYPpd{BqdiCycnXz[Y5k\SCxZjDOUWRCKHKnY3XweI9zKGGwdHHnc45qe3Ribnnm[YRqeGmwZR?= NVvjeJZ6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVI5OzJpPkG4OVUzQDN{PD;hQi=>
HCN MULGeY5kfGmxbjDhd5NigQ>? NYG2cGwxOjBidV2= MX3JcoR2[3Srb36gc4YhUESDQ{WgeJJidnOub3PheIlwdiCrbjDueYNt\XW|IH;mJJJifCCKQ16gZ4VtdHNiYYPz[ZN{\WRiYYOgS2ZRNUiGQVO1JIZ2e2mxbjDwdo91\WmwIHHjZ5VufWyjdHnvckBifCB{MDD1UUBjgSCobIXvdoV{[2WwY3WgZZN{[Xl? MmLNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh3NUK4N|IoRjF6NUWyPFMzRC:jPh?=
HCN NULqS4FNTnWwY4Tpc44h[XO|YYm= NHzZT4xKdmS3Y4Tpc44hd2ZiQ1HNT{1u\WSrYYTl[EBOWkW6MzDhZ5Rqfmm2eTDpckBz[XRiSFPOJINmdGy|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSCrbjDwdoV{\W6lZTDv[kAzODBibl2gVGtEKGmwaHnibZRweiCJb{[5O|Y> M1;rbVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NUWyPFMzLz5zOEW1Nlg{OjxxYU6=
HCN NUKyd2doTnWwY4Tpc44h[XO|YYm= NIrJe3ozPCCqcoO= NW\4UpZoUW6mdXP0bY9vKG:oIFyteJlx\SClYXzjbZVuKGOqYX7u[YwudWWmaXH0[YQhdmW3cn;EJIdmdmViZYjwdoV{e2mxbjDpckBz[XRiSFPOJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmgbY4heHKnc3XuZ4Uhd2ZibYXseIlxdGViaX7obYJqfG:{cx?= NET4fGg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEW1Nlg{Oid-MUi1OVI5OzJ:L3G+
HCN NWHne2VrTnWwY4Tpc44h[XO|YYm= MonVNlQhcHK| MWLJcoR2[3Srb36gc4YhVC22eYDlJINidGOrdX2gZ4hidm6nbD3t[YRq[XSnZDDu[ZVzd0RiZ3Xu[UBmgHC{ZYPzbY9vKGmwIILheEBJS05iY3XscJMh[W[2ZYKgNlQhcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSCrbjDwdoV{\W6lZTDv[kBPVUSDIILlZ4VxfG:{IHHueIFod26rc4SgUWs5ODF? MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDV3MkizNkc,OTh3NUK4N|I9N2F-
HCN NFvBVXVHfW6ldHnvckBie3OjeR?= NEO2eW8zPCCqcoO= NHSzcFRKdmS3Y4Tpc44hd2ZiTD30fZBmKGOjbHPpeY0h[2ijbn7lcE1u\WSrYYTl[EBv\XW{b1Sg[4Vv\SCneIDy[ZN{cW:wIHnuJJJifCCKQ16gZ4VtdHNiYX\0[ZIhOjRiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTDpckBxemW|ZX7j[UBw\iCQTVTBJJJm[2WydH;yJIFvfGGpb37pd5QhdmmoZXTpdIlv\Q>? NUSzVGs1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi1OVI5OzJpPkG4OVUzQDN{PD;hQi=>

... Click to View More Cell Line Experimental Data

In vivo In mice, isoxazole 9 (20 mg/kg, i.p.) crosses the BBB and increases proliferation of neuroblasts and neurogenesis via Mef2-specific mechanisms in the hippocampal SGZ. Isoxazole 9 (20 mg/kg, i.p.) also increases differentiation and dendritic complexity of immature neurons and improves memory. In MWM, isoxazole 9 improves spatial memory. [2]

Protocol

Cell Research:[1]
- Collapse
  • Cell lines: NSPCs, OPCs, early EPCs, and outgrowth EPCs
  • Concentrations: ~50 μM
  • Incubation Time: 48 h
  • Method: Cells are treated with different concentrations of Isx-9 (0, 6.25, 12.5, 25, or 50 μM), and 2 days later, cell numbers are counted in a blinded manner to evaluate the effects of Isx-9 on the proliferation/survival of four types of progenitor/precursor cells.
    (Only for Reference)
Animal Research:[2]
- Collapse
  • Animal Models: Transgenic Nkx2.5-luciferase reporter mice
  • Dosages: 20 mg/kg
  • Administration: i.p.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 46 mg/mL (196.35 mM)
Ethanol 13 mg/mL warmed (55.49 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5% DMSO+55% PEG 300+ddH2O
For best results, use promptly after mixing.
10mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 234.27
Formula

C11H10N2O2S

CAS No. 832115-62-5
Storage powder
in solvent
Synonyms N/A
Smiles C1CC1NC(=O)C2=NOC(=C2)C3=CC=CS3

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Wnt/beta-catenin Signaling Pathway Map

Related Wnt/beta-catenin Products

Tags: buy Isoxazole 9 (ISX-9) | Isoxazole 9 (ISX-9) supplier | purchase Isoxazole 9 (ISX-9) | Isoxazole 9 (ISX-9) cost | Isoxazole 9 (ISX-9) manufacturer | order Isoxazole 9 (ISX-9) | Isoxazole 9 (ISX-9) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID